Effectiveness, toxicity and impact on quality of life of high-dose-rate brachytherapy delivered in two fractions as monotherapy in patients with prostate cancer
Purpose: The aim of this retrospective, single-center cohort study was to evaluate the effectiveness and safety of two-fraction high-dose-rate brachytherapy (HDR-BT) as monotherapy in a consecutive cohort of prostate cancer patients. Methods: We included consecutive patients who received 28 Gy HDR-B...
Saved in:
| Main Authors: | Johan Staby Olsén, Antonis Valachis, Bengt Johansson |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | Clinical and Translational Radiation Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405630825000138 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prostate brachytherapy boost: Long-term results of protocol-based treatment of patients with non-metastatic prostate cancer
by: Claudia Schweizer, et al.
Published: (2024-12-01) -
Improving prostate brachytherapy outcomes through MRI-Assisted dominant lesion dose painting
by: Faranak Rahmani, et al.
Published: (2025-03-01) -
THE COMBINATION OF EXTERNAL RADIATION THERAPY WITH HIGH DOSE RATE BRAHYTERAPY BOOST FOR PROSTATE CANCER: A COMPARATIVE CHARACTERISTIC OF TWO FRACTION MODES
by: S. V. Kanaev, et al.
Published: (2020-03-01) -
A new approach to assess transit dose impact
in gynecological and prostate brachytherapy with effective transit time
by: Masato Nishitani, et al.
Published: (2024-12-01) -
Dosiomic predictors of biochemical failure in patients with localized prostate cancer treated with Iodine-125 low-dose-rate brachytherapy
by: Masahiro Nakano, et al.
Published: (2025-04-01)